Outlook Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SYNTONE VENTURES LLC 10 percent owner
 Common Stock 714,286 $7 $5,000,002
Purchase
SYNTONE VENTURES LLC 10 percent owner
 Warrant (Right to Buy) 1,071,429 $7.7 $8,250,003
Purchase
HADDADIN YEZAN MUNTHER director
 Common Stock 1,881 $11.82 $22,233
Purchase
EVANSON JEFF officer: CHIEF COMMERCIAL OFFICER
 Common Stock 62,484 $0.42 $26,243
Sale
DAGNON TERRY officer: Chief Operations Officer
 Common Stock 520,000 $1.14 $590,200
Sale
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 267,000 $1.11 $296,370
Sale
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 103,255 $1.22 $125,971
Sale
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 33,738 $1.25 $42,173
Sale
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 27,162 $1.31 $35,582
Purchase
SUKHTIAN FAISAL GHIATH director
 Common Stock 30,000 $1.29 $38,700
Purchase
HADDADIN YEZAN MUNTHER director
 Common Stock 3,600 $1.27 $4,572
Purchase
HADDADIN YEZAN MUNTHER director
 Common Stock 29,743 $1.29 $38,368
Purchase
HILZINGER KURT J director
 Common Stock 15,662 $1.23 $19,264
Purchase
HILZINGER KURT J director
 Common Stock 95,541 $1.29 $123,248
Purchase
HILZINGER KURT J director
 Common Stock 41,798 $1.25 $52,248
Purchase
HILZINGER KURT J director
 Common Stock 33,199 $1.26 $41,831
Purchase
HILZINGER KURT J director
 Common Stock 13,800 $1.19 $16,422
Purchase
TRENARY C RUSSELL III director, officer: CEO and Pres..
 Common Stock 19,925 $1.06 $21,121
Purchase
DAGNON TERRY officer: Chief Operating Officer
 Common Stock 10,000 $1.05 $10,500
Purchase
HILZINGER KURT J director
 Common Stock 27,708 $1.69 $46,827
Purchase
HILZINGER KURT J director
 Common Stock 6,000 $1.6 $9,600
Purchase
HILZINGER KURT J director
 Common Stock 41,160 $1.46 $60,094
Purchase
HILZINGER KURT J director
 Common Stock 79,535 $1.44 $114,530
Purchase
HILZINGER KURT J director
 Common Stock 95,597 $1.49 $142,440
Purchase
TRENARY C RUSSELL III director, officer: CEO and Pres..
 Common Stock 25,000 $1.39 $34,750
Purchase
DAGNON TERRY officer: Chief Operating Officer
 Common Stock 25,201 $1.38 $34,777
Purchase
DAGNON TERRY officer: Chief Operating Officer
 Common Stock 10,000 $1.42 $14,200
Purchase
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 35,200 $1.34 $47,168
Purchase
TRENARY C RUSSELL III director, officer: CEO and Pres..
 Common Stock 10,000 $1.4 $14,000
Purchase
SUKHTIAN FAISAL GHIATH director
 Common Stock 18,000 $1.4 $25,200
Purchase
HADDADIN YEZAN MUNTHER director
 Common Stock 10,000 $1.39 $13,900
Purchase
SUKHTIAN GHIATH M. director, 10 percent owner
 Common Stock 16,000,000 $1.25 $20,000,000
Purchase
KENYON LAWRENCE A director, officer: CEO, Pres, C..
 Common Stock 10,000 $1.83 $18,300
Purchase
HADDADIN YEZAN MUNTHER director
 Common Stock 10,000 $1.82 $18,200
Purchase
SUKHTIAN FAISAL GHIATH director
 Common Stock 10,000 $1.82 $18,200
Sale
DAGNON TERRY officer: Chief Operating Officer
 Common Stock 15,900 $2.09 $33,199
Sale
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 8,554 $2.09 $17,861
Sale
DAGNON TERRY officer: Chief Operating Officer
 Common Stock 63,700 N/A N/A
Sale
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 56,973 $2.55 $145,281
Purchase
SYNTONE VENTURES LLC 10 percent owner
 Common Stock 3,000,000 $1 $3,000,000
Purchase
SUKHTIAN GHIATH M. director, 10 percent owner
 Common Stock 8,360,000 N/A N/A
Purchase
HADDADIN YEZAN MUNTHER director
 Common Stock 10,000 $0.73 $7,250
Purchase
SUKHTIAN FAISAL GHIATH director
 Common Stock 10,000 $0.67 $6,730
Purchase
THURMAN RANDY H director
 Common Stock 10,000 $0.62 $6,200
Purchase
SYNTONE VENTURES LLC 10 percent owner
 Common Stock 823,045 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Common Stock 29,358,621 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Series A-1 Convertible Preferred Stock 68,112 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Common Stock 4,657,852 $0.23 $1,080,622
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Warrant (Right to Buy) 2,093,750 $7.2 $15,075,000
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Warrant (Right to Buy) 3,636,364 N/A N/A

Showing 1 to 50 of 110 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: